0
0
0
0
1
2
3
$0
Is Freeport-McMoRan solid or fragile? The Finex Financial Health Scanner reads FCX's real financial statements and scores its debt, liquidity, margins, cash flow and growth, with the Altman Z-score, the Piotroski F-score and the red flags explained in plain words.
| Revenue (FY2025) | $25.9B |
|---|---|
| Net income | $2.2B |
| Operating margin | 25.2% |
| Net margin | 8.6% |
| Cash and investments | $4.1B |
| Total debt | $9.4B |
| Free cash flow | $1.9B |
| Revenue growth (1 year) | 1.8% |
Data: Nasdaq and Yahoo Finance. Educational, not financial advice.